109 related articles for article (PubMed ID: 14696015)
1. Gene expression profiling in the midbrain of striatal 6-hydroxydopamine-injected mice.
Iwata S; Nomoto M; Morioka H; Miyata A
Synapse; 2004 Mar; 51(4):279-86. PubMed ID: 14696015
[TBL] [Abstract][Full Text] [Related]
2. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway.
Ge H; Yan Z; Zhu H; Zhao H
Exp Mol Pathol; 2019 Aug; 109():16-24. PubMed ID: 31067440
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
Porritt MJ; Batchelor PE; Howells DW
Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
[TBL] [Abstract][Full Text] [Related]
4. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
5. Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling.
Weng Z; Signore AP; Gao Y; Wang S; Zhang F; Hastings T; Yin XM; Chen J
J Biol Chem; 2007 Nov; 282(47):34479-91. PubMed ID: 17895242
[TBL] [Abstract][Full Text] [Related]
6. NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson's disease.
Cheng L; Chen L; Wei X; Wang Y; Ren Z; Zeng S; Zhang X; Wen H; Gao C; Liu H
J Neuroinflammation; 2018 Aug; 15(1):243. PubMed ID: 30157869
[TBL] [Abstract][Full Text] [Related]
7. Gender-specific role of mitochondria in the vulnerability of 6-hydroxydopamine-treated mesencephalic neurons.
Misiak M; Beyer C; Arnold S
Biochim Biophys Acta; 2010; 1797(6-7):1178-88. PubMed ID: 20416276
[TBL] [Abstract][Full Text] [Related]
8. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
[TBL] [Abstract][Full Text] [Related]
9. Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death.
Park B; Oh CK; Choi WS; Chung IK; Youdim MB; Oh YJ
J Neural Transm (Vienna); 2011 Nov; 118(11):1585-98. PubMed ID: 21904894
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.
Shi XR; Hong ZY; Liu HR; Zhang YC; Zhu YZ
Neurochem Int; 2011 Jul; 58(8):851-60. PubMed ID: 21093517
[TBL] [Abstract][Full Text] [Related]
11. Tetramethylpyrazine Analogue CXC195 Protects Against Dopaminergic Neuronal Apoptosis via Activation of PI3K/Akt/GSK3β Signaling Pathway in 6-OHDA-Induced Parkinson's Disease Mice.
Chen L; Cheng L; Wei X; Yuan Z; Wu Y; Wang S; Ren Z; Liu X; Liu H
Neurochem Res; 2017 Apr; 42(4):1141-1150. PubMed ID: 28005221
[TBL] [Abstract][Full Text] [Related]
12. 6-OHDA-Induced Changes in Parkinson's Disease-Related Gene Expression are not Affected by the Overexpression of PGAM5 in In Vitro Differentiated Embryonic Mesencephalic Cells.
Stępkowski TM; Wasyk I; Grzelak A; Kruszewski M
Cell Mol Neurobiol; 2015 Nov; 35(8):1137-47. PubMed ID: 25986246
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53.
Liang ZQ; Li YL; Zhao XL; Han R; Wang XX; Wang Y; Chase TN; Bennett MC; Qin ZH
Brain Res; 2007 May; 1145():190-203. PubMed ID: 17368433
[TBL] [Abstract][Full Text] [Related]
14. Lateromedial gradient of the susceptibility of midbrain dopaminergic neurons to neonatal 6-hydroxydopamine toxicity.
Okamura H; Yokoyama C; Ibata Y
Exp Neurol; 1995 Dec; 136(2):136-42. PubMed ID: 7498403
[TBL] [Abstract][Full Text] [Related]
15. Microsomal prostaglandin E synthase-1 is a critical factor in dopaminergic neurodegeneration in Parkinson's disease.
Ikeda-Matsuo Y; Miyata H; Mizoguchi T; Ohama E; Naito Y; Uematsu S; Akira S; Sasaki Y; Tanabe M
Neurobiol Dis; 2019 Apr; 124():81-92. PubMed ID: 30423474
[TBL] [Abstract][Full Text] [Related]
16. Loss of Nogo-A-expressing neurons in a rat model of Parkinson's disease.
Schawkat K; Di Santo S; Seiler S; Ducray AD; Widmer HR
Neuroscience; 2015 Mar; 288():59-72. PubMed ID: 25554426
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of the beneficial effect of melatonin in experimental Parkinson's disease.
Yildirim FB; Ozsoy O; Tanriover G; Kaya Y; Ogut E; Gemici B; Dilmac S; Ozkan A; Agar A; Aslan M
Neurochem Int; 2014 Dec; 79():1-11. PubMed ID: 25263280
[TBL] [Abstract][Full Text] [Related]
18. Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of Parkinson's disease does not involve activation of caspase-9 and caspase-3.
Ebert AD; Hann HJ; Bohn MC
J Neurosci Res; 2008 Feb; 86(2):317-25. PubMed ID: 17787016
[TBL] [Abstract][Full Text] [Related]
19. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.
Rodriguez-Blanco J; Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez C
J Neurochem; 2008 Oct; 107(1):127-40. PubMed ID: 18665912
[TBL] [Abstract][Full Text] [Related]
20. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
